Safety and tolerability of Bifidobacterium longum subspecies infantis EVC001 supplementation in healthy term breastfed infants: a phase I clinical trial
- 2017-05-30
- BMC Pediatrics 17(1)
- J. Smilowitz
- Jackelyn Moya
- Melissa A. Breck
- Chelsea Cook
- A. Fineberg
- K. Angkustsiri
- M. Underwood
- PubMed: 28558732
- DOI: 10.1186/s12887-017-0886-9
- Low evidence
- Rigorous Journal
The mean Log10 change in fecal Bifidobacterium from Day 6 to Day 28 was higher (p = 0.0002) for BiLS (6.6 ± 2.8 SD) than for LS infants (3.5 ± 3.5 SD).
- Effect
- Beneficial
- Effect size
- Large
- Significant
- Yes